Insider-Trading
Aktuelle Insider-Transaktionen (SEC Form 4) — Käufe und Verkäufe von Vorständen, Direktoren und Großaktionären.
| Ticker | Insider | Funktion | Datum | Transaktion | Kurs ($) | Stück | Wert ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| TEAM | Chuong James | Chief Financial Officer | 19.08.2026 | Verkauf | 173,14 | 2.143 | 371.036 | Form 4 |
| TEAM | Chuong James | Chief Financial Officer | 19.08.2026 | Verkauf | 170,05 | 107 | 18.195 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 19.08.2026 | Verkauf | 174,02 | 418 | 72.741 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 19.08.2026 | Verkauf | 165,08 | 18 | 2.971 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 19.08.2026 | Verkauf | 171,31 | 117 | 20.044 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 19.08.2026 | Verkauf | 175,10 | 242 | 42.375 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 19.08.2026 | Verkauf | 170,05 | 22 | 3.741 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 19.08.2026 | Verkauf | 167,15 | 116 | 19.389 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 19.08.2026 | Verkauf | 165,96 | 40 | 6.639 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 19.08.2026 | Verkauf | 175,76 | 54 | 9.491 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 19.08.2026 | Verkauf | 173,14 | 438 | 75.835 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 19.08.2026 | Verkauf | 162,05 | 5 | 810 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 19.08.2026 | Verkauf | 172,01 | 281 | 48.334 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 19.08.2026 | Verkauf | 169,09 | 31 | 5.242 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 19.08.2026 | Verkauf | 167,99 | 69 | 11.591 | Form 4 |
| TEAM | Liu Gene | Chief Accounting Officer | 19.08.2026 | Verkauf | 175,00 | 1.125 | 196.875 | Form 4 |
| TENB | Zecher Linda Kay | Director | 18.08.2026 | Verkauf | 35,46 | 700 | 24.822 | Form 4 |
| TEM | Schoenherr Thomas Edward | CEO, Diagnostics | 18.08.2026 | Verkauf | 49,61 | 9.232 | 458.000 | Form 4 |
| TEM | Rogers James William | Chief Financial Officer | 18.08.2026 | Verkauf | 49,61 | 22.529 | 1.117.664 | Form 4 |
| TEM | Fukushima Ryan | CEO, Data | 18.08.2026 | Verkauf | 49,61 | 41.095 | 2.038.723 | Form 4 |
| TEM | Polovin Andrew | EVP, Chief Legal Officer | 18.08.2026 | Verkauf | 49,61 | 22.148 | 1.098.762 | Form 4 |
| TEM | Bartolucci Ryan M | Chief Accounting Officer | 18.08.2026 | Verkauf | 49,61 | 6.175 | 306.342 | Form 4 |
| TEM | Lefkofsky Eric P | CEO and Chairman | 18.08.2026 | Verkauf | 49,61 | 132.591 | 6.577.840 | Form 4 |
| TEVA | Lippman Evan | EVP, Business Development | 17.08.2026 | Verkauf | 36,57 | 18.600 | 680.291 | Form 4 |
| TELA | Getz Heather C | Chief Executive Officer | 17.08.2026 | Kauf | 0,6649 | 12.500 | 8.311 | Form 4 |
| TER | Smith Gregory Stephen | President and CEO | 17.08.2026 | Verkauf | 425,00 | 4.000 | 1.700.000 | Form 4 |
| TER | Matz Marilyn | Director | 17.08.2026 | Verkauf | 425,00 | 1.200 | 510.000 | Form 4 |
| TECH | Kelderman Kim | Chief Executive Officer | 15.08.2026 | Steuer-Abgabe | 72,40 | 10.821 | 783.440 | Form 4 |
| TECH | Kelderman Kim | Chief Executive Officer | 15.08.2026 | Optionsausübung | — | 21.470 | — | Form 4 |
| TECH | Hippel James | CFO | 15.08.2026 | Steuer-Abgabe | 72,40 | 4.310 | 312.044 | Form 4 |
| TECH | Hippel James | CFO | 15.08.2026 | Optionsausübung | — | 9.779 | — | Form 4 |
| TECH | Geist William | PRESIDENT, PROTEIN SCIENCES | 15.08.2026 | Steuer-Abgabe | 72,40 | 1.976 | 143.062 | Form 4 |
| TECH | Geist William | PRESIDENT, PROTEIN SCIENCES | 15.08.2026 | Optionsausübung | — | 6.416 | — | Form 4 |
| TECH | Bohnen Shane | SVP - General Counsel | 15.08.2026 | Steuer-Abgabe | 72,40 | 1.343 | 97.233 | Form 4 |
| TECH | Bohnen Shane | SVP - General Counsel | 15.08.2026 | Optionsausübung | — | 4.350 | — | Form 4 |
| TECH | Crouse Steven C. | President - Diag & Spatial Bi | 15.08.2026 | Steuer-Abgabe | 72,40 | 1.947 | 140.963 | Form 4 |
| TECH | Crouse Steven C. | President - Diag & Spatial Bi | 15.08.2026 | Optionsausübung | — | 5.423 | — | Form 4 |
| TECH | Herr Amy E. | Director | 15.08.2026 | Steuer-Abgabe | 72,40 | 213 | 15.421 | Form 4 |
| TECH | Herr Amy E. | Director | 15.08.2026 | Optionsausübung | — | 589 | — | Form 4 |
| TEM | West Nadja | Director | 14.08.2026 | Verkauf | 53,90 | 3.000 | 161.700 | Form 4 |
| TELA | Getz Heather C | Chief Executive Officer | 14.08.2026 | Kauf | 0,6978 | 15.000 | 10.467 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 14.08.2026 | Verkauf | 163,22 | 1.472 | 240.262 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 14.08.2026 | Verkauf | 162,38 | 4.600 | 746.925 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 14.08.2026 | Verkauf | 167,29 | 24 | 4.015 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 14.08.2026 | Verkauf | 166,40 | 125 | 20.801 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 14.08.2026 | Verkauf | 165,15 | 231 | 38.149 | Form 4 |
| TEAM | Duffy Brian | Chief Revenue Officer | 14.08.2026 | Verkauf | 164,29 | 1.165 | 191.401 | Form 4 |
| TEAM | Liu Gene | Chief Accounting Officer | 14.08.2026 | Verkauf | 165,15 | 25 | 4.129 | Form 4 |
| TEAM | Liu Gene | Chief Accounting Officer | 14.08.2026 | Verkauf | 164,29 | 125 | 20.537 | Form 4 |
| TEAM | Liu Gene | Chief Accounting Officer | 14.08.2026 | Verkauf | 163,22 | 157 | 25.626 | Form 4 |
| TEAM | Liu Gene | Chief Accounting Officer | 14.08.2026 | Verkauf | 162,38 | 492 | 79.889 | Form 4 |
| TEAM | Liu Gene | Chief Accounting Officer | 14.08.2026 | Verkauf | 167,29 | 3 | 502 | Form 4 |
| TEAM | Liu Gene | Chief Accounting Officer | 14.08.2026 | Verkauf | 166,40 | 13 | 2.163 | Form 4 |
| TEN-PF | Hatzimichalis Clio | Director | 13.08.2026 | Verkauf | 41,07 | 5.000 | 205.331 | Form 4 |
| TEAM | Liu Gene | Chief Accounting Officer | 13.08.2026 | Verkauf | 165,00 | 737 | 121.605 | Form 4 |
| TEM | Fukushima Ryan | CEO, Data | 12.08.2026 | Schenkung | — | 62.239 | — | Form 4 |
| TECX | McNamara Peter | Chief Scientific Officer | 12.08.2026 | Verkauf | 35,00 | 43 | 1.505 | Form 4 |
| TECX | McNamara Peter | Chief Scientific Officer | 12.08.2026 | Optionsausübung | 14,71 | 43 | 633 | Form 4 |
| TENB | Vicks Raymond Jr. | Director | 07.08.2026 | Verkauf | 35,94 | 1.819 | 65.375 | Form 4 |
| TENB | Zecher Linda Kay | Director | 07.08.2026 | Verkauf | 36,50 | 550 | 20.075 | Form 4 |
Kompakter Markt-Überblick — keine Anlageberatung. Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q).